美年健康: 粤开证券股份有限公司关于美年大健康产业控股股份有限公司本次交易信息公布前股票价格波动情况的核查意见

Group 1 - The company intends to acquire significant stakes in multiple health management and medical examination centers across various locations, including Hunan, Ningde, Yantai, Wuhan, and others, through a share issuance [1] - The stakes to be acquired range from 49.00% to 92.35% in different subsidiaries, indicating a strategic expansion in the health management sector [1] Group 2 - An independent financial advisor conducted a review of the stock price fluctuations prior to the announcement of the transaction, covering a 20-day trading period from March 14, 2025, to April 14, 2025 [2] - The review found that the company's stock price did not exhibit abnormal fluctuations, with a cumulative price change of less than 20% after excluding market and industry influences [2] - Specifically, the stock price showed a decline of 4.34% when adjusted for market factors and a decline of 5.95% when adjusted for industry factors during the review period [2]